BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23383720)

  • 1. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.
    Bainbridge MN; Hu H; Muzny DM; Musante L; Lupski JR; Graham BH; Chen W; Gripp KW; Jenny K; Wienker TF; Yang Y; Sutton VR; Gibbs RA; Ropers HH
    Genome Med; 2013; 5(2):11. PubMed ID: 23383720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.
    Kuechler A; Czeschik JC; Graf E; Grasshoff U; Hüffmeier U; Busa T; Beck-Woedl S; Faivre L; Rivière JB; Bader I; Koch J; Reis A; Hehr U; Rittinger O; Sperl W; Haack TB; Wieland T; Engels H; Prokisch H; Strom TM; Lüdecke HJ; Wieczorek D
    Eur J Hum Genet; 2017 Feb; 25(2):183-191. PubMed ID: 27901041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A
    Zhao W; Hu X; Liu Y; Wang X; Chen Y; Wang Y; Zhou H
    Front Pediatr; 2021; 9():678615. PubMed ID: 34527642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding our knowledge of conditions associated with the ASXL gene family.
    Russell B; Graham JM
    Genome Med; 2013; 5(2):16. PubMed ID: 23672984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
    Hoischen A; van Bon BW; Rodríguez-Santiago B; Gilissen C; Vissers LE; de Vries P; Janssen I; van Lier B; Hastings R; Smithson SF; Newbury-Ecob R; Kjaergaard S; Goodship J; McGowan R; Bartholdi D; Rauch A; Peippo M; Cobben JM; Wieczorek D; Gillessen-Kaesbach G; Veltman JA; Brunner HG; de Vries BB
    Nat Genet; 2011 Jun; 43(8):729-31. PubMed ID: 21706002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
    Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
    Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo nonsense mutation in
    Koboldt DC; Mihalic Mosher T; Kelly BJ; Sites E; Bartholomew D; Hickey SE; McBride K; Wilson RK; White P
    Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29305346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
    Dangiolo SB; Wilson A; Jobanputra V; Anyane-Yeboa K
    Am J Med Genet A; 2015 Dec; 167A(12):3161-6. PubMed ID: 26364555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome.
    Zhao J; Hou Y; Fang F; Ding C; Yang X; Li J; Cui D; Cao Z; Zhang H
    Eur J Med Genet; 2021 Mar; 64(3):104155. PubMed ID: 33529703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions.
    Yu KP; Luk HM; Fung JLF; Chung BH; Lo IF
    Eur J Med Genet; 2021 Jan; 64(1):104107. PubMed ID: 33242595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with
    Balasubramanian M; Willoughby J; Fry AE; Weber A; Firth HV; Deshpande C; Berg JN; Chandler K; Metcalfe KA; Lam W; Pilz DT; Tomkins S
    J Med Genet; 2017 Aug; 54(8):537-543. PubMed ID: 28100473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.
    Russell B; Johnston JJ; Biesecker LG; Kramer N; Pickart A; Rhead W; Tan WH; Brownstein CA; Kate Clarkson L; Dobson A; Rosenberg AZ; Vergano SA; Helm BM; Harrison RE; Graham JM
    Am J Med Genet A; 2015 Sep; 167A(9):2122-31. PubMed ID: 25921057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Bainbridge-Ropers Syndrome in
    Lichtig H; Artamonov A; Polevoy H; Reid CD; Bielas SL; Frank D
    Front Physiol; 2020; 11():75. PubMed ID: 32132929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations.
    Magini P; Della Monica M; Uzielli ML; Mongelli P; Scarselli G; Gambineri E; Scarano G; Seri M
    Am J Med Genet A; 2012 Apr; 158A(4):917-21. PubMed ID: 22419483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo nonsense variant in ASXL3 in a Chinese girl causing Bainbridge-Ropers syndrome: A case report and review of literature.
    Wang Q; Zhang J; Jiang N; Xie J; Yang J; Zhao X
    Mol Genet Genomic Med; 2022 May; 10(5):e1924. PubMed ID: 35276034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3).
    Ayoub MC; Anderson JT; Russell BE; Wilson RB
    Front Neurosci; 2023; 17():1244176. PubMed ID: 38027485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.
    Srivastava A; Ritesh KC; Tsan YC; Liao R; Su F; Cao X; Hannibal MC; Keegan CE; Chinnaiyan AM; Martin DM; Bielas SL
    Hum Mol Genet; 2016 Feb; 25(3):597-608. PubMed ID: 26647312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report.
    Yang L; Guo B; Zhu W; Wang L; Han B; Che Y; Guo L
    BMC Pediatr; 2020 Jun; 20(1):287. PubMed ID: 32517662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.